Prelude Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,632
| Closed | -$2.73M | – | 1331 |
|
|
2025
Q1 | $2.73M | Sell |
5,632
-30
| -0.5% | -$14.5K | 0.21% | 76 |
|
|
2024
Q4 | $2.28M | Sell |
5,662
-243
| -4% | -$97.9K | 0.14% | 131 |
|
|
2024
Q3 | $2.75M | Buy |
5,905
+29
| +0.5% | +$13.5K | 0.17% | 130 |
|
|
2024
Q2 | $2.75M | Buy |
5,876
+104
| +2% | +$48.7K | 0.19% | 121 |
|
|
2024
Q1 | $2.41M | Sell |
5,772
-1,081
| -16% | -$452K | 0.13% | 178 |
|
|
2023
Q4 | $2.79M | Buy |
6,853
+872
| +15% | +$355K | 0.18% | 106 |
|
|
2023
Q3 | $2.08M | Sell |
5,981
-577
| -9% | -$201K | 0.14% | 153 |
|
|
2023
Q2 | $2.31M | Buy |
6,558
+5,713
| +676% | +$2.01M | 0.15% | 150 |
|
|
2023
Q1 | $266K | Sell |
845
-489
| -37% | -$154K | 0.02% | 619 |
|
|
2022
Q4 | $385K | Buy |
+1,334
| New | +$385K | 0.02% | 595 |
|
|
2022
Q2 | – | Sell |
-6,587
| Closed | -$1.72M | – | 1852 |
|
|
2022
Q1 | $1.72M | Buy |
6,587
+3,237
| +97% | +$845K | 0.05% | 304 |
|
|
2021
Q4 | $736K | Buy |
3,350
+1,096
| +49% | +$241K | 0.02% | 598 |
|
|
2021
Q3 | $409K | Buy |
+2,254
| New | +$409K | 0.01% | 747 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1880 |
|
|
2020
Q2 | – | Sell |
-3,204
| Closed | -$762K | – | 1727 |
|
|
2020
Q1 | $762K | Sell |
3,204
-1,566
| -33% | -$372K | 0.05% | 127 |
|
|
2019
Q4 | $1.04M | Sell |
4,770
-3,076
| -39% | -$673K | 0.04% | 188 |
|
|
2019
Q3 | $1.33M | Buy |
7,846
+6,533
| +498% | +$1.11M | 0.06% | 123 |
|
|
2019
Q2 | $241K | Sell |
1,313
-3,007
| -70% | -$552K | 0.01% | 420 |
|
|
2019
Q1 | $795K | Buy |
4,320
+3,714
| +613% | +$683K | 0.04% | 199 |
|
|
2018
Q4 | $100K | Sell |
606
-9,464
| -94% | -$1.56M | 0.01% | 680 |
|
|
2018
Q3 | $1.94M | Sell |
10,070
-21,858
| -68% | -$4.21M | 0.11% | 136 |
|
|
2018
Q2 | $5.43M | Buy |
31,928
+13,662
| +75% | +$2.32M | 0.34% | 37 |
|
|
2018
Q1 | $2.98M | Sell |
18,266
-5,499
| -23% | -$896K | 0.22% | 66 |
|
|
2017
Q4 | $3.56M | Buy |
23,765
+4,010
| +20% | +$601K | 0.29% | 55 |
|
|
2017
Q3 | $3M | Buy |
19,755
+4,461
| +29% | +$678K | 0.27% | 70 |
|
|
2017
Q2 | $1.97M | Buy |
15,294
+8,225
| +116% | +$1.06M | 0.19% | 110 |
|
|
2017
Q1 | $773K | Buy |
+7,069
| New | +$773K | 0.07% | 246 |
|
|
2016
Q4 | – | Sell |
-2,331
| Closed | -$203K | – | 1735 |
|
|
2016
Q3 | $203K | Buy |
+2,331
| New | +$203K | 0.02% | 508 |
|
|
2016
Q2 | – | Sell |
-1,779
| Closed | -$141K | – | 1698 |
|
|
2016
Q1 | $141K | Sell |
1,779
-5,209
| -75% | -$413K | 0.02% | 590 |
|
|
2015
Q4 | $879K | Buy |
6,988
+1,105
| +19% | +$139K | 0.14% | 156 |
|
|
2015
Q3 | $613K | Sell |
5,883
-202
| -3% | -$21K | 0.09% | 212 |
|
|
2015
Q2 | $751K | Sell |
6,085
-730
| -11% | -$90.1K | 0.11% | 210 |
|
|
2015
Q1 | $804K | Buy |
6,815
+4,080
| +149% | +$481K | 0.11% | 219 |
|
|
2014
Q4 | $325K | Sell |
2,735
-2,049
| -43% | -$243K | 0.05% | 440 |
|
|
2014
Q3 | $537K | Buy |
4,784
+795
| +20% | +$89.2K | 0.08% | 312 |
|
|
2014
Q2 | $378K | Sell |
3,989
-3,869
| -49% | -$367K | 0.05% | 425 |
|
|
2014
Q1 | $556K | Buy |
7,858
+4,613
| +142% | +$326K | 0.07% | 310 |
|
|
2013
Q4 | $241K | Sell |
3,245
-510
| -14% | -$37.9K | 0.04% | 518 |
|
|
2013
Q3 | $285K | Sell |
3,755
-4,391
| -54% | -$333K | 0.05% | 375 |
|
|
2013
Q2 | $652K | Buy |
+8,146
| New | +$652K | 0.14% | 162 |
|